Sorafenib-Associated Translation Reprogramming in Hepatocellular Carcinoma Cells

Researchers performed a genome-wide polysome profiling analysis in sorafenib-treated HCC cells and demonstrated that, despite global translation repression, a set of different genes remained efficiently translated or were even translationally induced.